Results 11 to 20 of about 54,247 (234)

Mumps serological surveillance following 10 years of a one-dose mumps-containing-vaccine policy in Fujian Province, China

open access: yesHuman Vaccines & Immunotherapeutics, 2022
Background Since 2008, Fujian province provided measles-rubella (MR) vaccine at 8 months followed by measles-mumps-rubella (MMR) vaccine at 18 months a one-dose mumps-containing-vaccine (MuCV) schedule.
Dong Li   +8 more
doaj   +2 more sources

Epidemiology of mumps, mumps complications, and mumps orchitis in Korea using the National Health Insurance Service database [PDF]

open access: yesInvestigative and Clinical Urology, 2023
Purpose: To analyze the presentation of mumps and mumps orchitis using the National Health Insurance Service Database (NHISD). Materials and Methods: Using information from the NHISD representing all cases of mumps in Korea, data regarding mumps ...
Jung Wan Yoo   +6 more
doaj   +1 more source

Determination of ELISA reactive mumps IgG antibodies in MMR vaccine recipients in comparison with MMR vaccine naive children: A cross sectional study [PDF]

open access: yesScripta Medica, 2021
Background/Aim: Mumps is by vaccine preventable infectious disease characterised by parotitis. In India mumps vaccines are not currently used under National Immunisation Programme (NIP).
Gupta Riya, Saxena Naveen, Gupta Parul
doaj   +1 more source

Mumps-Related Disease Burden in Japan: Analysis of JMDC Health Insurance Reimbursement Data for 2005–2017

open access: yesJournal of Epidemiology, 2021
Background: Mumps vaccination coverage is low in Japan, partly because of its voluntary nature. Although pediatric cases of mumps virus infection are captured by the National Epidemiological Surveillance of Infectious Diseases program under the ...
Satoko Ohfuji   +5 more
doaj   +1 more source

Incidence of Mumps Deafness in Japan, 2005–2017: Analysis of Japanese Insurance Claims Database

open access: yesJournal of Epidemiology, 2022
Background: Mumps deafness causes serious problems, and incidence data are needed to identify its disease burden. However, such data are limited, and the reported incidence is highly variable.
Akira Takagi   +5 more
doaj   +1 more source

Mumps Vaccines: Current Challenges and Future Prospects

open access: yesFrontiers in Microbiology, 2020
Five decades have passed since the first mumps vaccine was licensed. Over this period, a resurgence of mumps infections has been recorded worldwide. Although global mumps infections have been controlled through vaccination, outbreaks are still on the ...
Iman Almansour
doaj   +1 more source

Impact of vaccine effectiveness and coverage on preventing large mumps outbreaks on college campuses: Implications for vaccination strategy

open access: yesEpidemics, 2022
Recent mumps outbreaks among highly vaccinated populations, including college students, have called into question the vaccine effectiveness (VE) of routine two-dose measles, mumps, and rubella (MMR2) immunization. We aimed to estimate the VE required for
Michael Melgar   +2 more
doaj   +1 more source

Upward Trends of Parotitis and Mumps in Atlanta over a Decade

open access: yesGlobal Pediatric Health, 2020
Rising rates of mumps in Georgia have been reported. We hypothesize that the incidence of parotitis and mumps presenting to Children’s Healthcare of Atlanta (CHOA) has increased over the past decade among immunized children.
Lankala M. Reddy MD   +9 more
doaj   +1 more source

Acute hydrocephalus in a case of mumps meningoencephalitis: A rare occurrence

open access: yesJournal of Pediatric Neurosciences, 2020
Mumps is an acute viral illness, which presents with glandular and/or nervous system involvement. The most common central nervous system manifestations of mumps include aseptic meningitis and meningoencephalitis.
Anish Mehta   +5 more
doaj   +1 more source

Sero-epidemiology of mumps in western Europe. [PDF]

open access: yes, 2003
Six countries (Denmark, England and Wales, France, Germany, Italy and The Netherlands) conducted large serological surveys for mumps, in the mid-1990s, as part of the European Sero-Epidemiology Network (ESEN).
Edmunds, WJ   +27 more
core   +1 more source

Home - About - Disclaimer - Privacy